KALARIS THERAPEUTICS, INC. (KLRS) Net income 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$43.4MFY2025 · since FY2019: -$23.8M → -$43.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.4M | +37.2% |
| FY2024 | -$69.2M | +63.7% |
| FY2023 | -$190.4M | -12.9% |
| FY2022 | -$168.7M | +1.9% |
| FY2021 | -$172.0M | -146.4% |
| FY2020 | -$69.8M | -192.7% |
| FY2019 | -$23.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KLRS financial trends
KLRS RevenueKLRS Net marginKLRS Gross profitKLRS Gross marginKLRS Operating incomeKLRS Operating marginKLRS Operating cash flowKLRS Free cash flowKLRS Capital expendituresKLRS Return on equityKLRS Stock buybacksKLRS Dividends paidKLRS Total assetsKLRS Total liabilitiesKLRS Shareholders’ equityKLRS overview →